Showing results (241-250 of 284) with videos related to
Sort By:
Pageof 29
Journal of the Neurological Sciences|October 10, 2009
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH RegistryShinichiro Uchiyama, Shinya Goto, Masayasu Matsumoto, et al.Japanese Journal of Cancer Research : Gann|October 3, 2002
Thalidomide for the treatment of refractory multiple myeloma: association of plasma concentrations of thalidomide and angiogenic growth factors with clinical outcomeTsunayuki Kakimoto, Yutaka Hattori, Shinichiro Okamoto, et al.International Journal of Hematology|March 12, 2003
Multicenter prospective study of clonal complications in adult aplastic anemia patients following recombinant human granulocyte colony-stimulating factor (lenograstim) administrationMasami Bessho, Tomomitsu Hotta, Kazuma Ohyashiki, et al.American Heart Journal|March 10, 2010
Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-a randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular eventsTamio Teramoto, Kazuyuki Shimada, Shinichiro Uchiyama, et al.Journal of Cardiology|November 2, 2015
Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: The PRASFIT-ACS studyHisao Ogawa, Takaaki Isshiki, Takeshi Kimura, et al.International Journal of Hematology|July 31, 2013
Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension studyShinya Katsutani, Yoshiaki Tomiyama, Akiro Kimura, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 20, 2018
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70)Masahiro Sugawara, Yoshio Goto, Tsutomu Yamazaki, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|June 26, 2007
Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in JapanTsutomu Yamazaki, Shinya Goto, Hiroshi Shigematsu, et al.Nature|October 22, 2004
Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cellsKeisuke Ito, Atsushi Hirao, Fumio Arai, et al.Japanese Journal of Cancer Research : Gann|May 3, 2002
Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activityNorihide Sato, Yutaka Hattori, Du Wenlin, et al.Pageof 29